Neonatal BCG vaccination and atopic dermatitis before 13 months of age: A randomized clinical trial

Authors :: Jesper Kjaergaard
Poul-Erik Kofoed
Nina Marie Birk
Lone Graff Stensballe
Dorthe Lisbeth Jeppesen
Annette Wind Olesen
Lisbeth Marianne Thøstesen
Thomas Nørrelykke Nissen
Christine Stabell Benn
Peter Aaby
Aksel Karl Georg Jensen
Gitte Thybo Pihl
Source :: Thøstesen, L M, Kjaergaard, J, Pihl, G T, Birk, N M, Nissen, T N, Aaby, P, Jensen, A K G, Olesen, A W, Stensballe, L G, Jeppesen, D L, Benn, C S & Kofoed, P-E 2018, ' Neonatal BCG vaccination and atopic dermatitis before 13 months of age : A randomized clinical trial ', Allergy: European Journal of Allergy and Clinical Immunology, vol. 73, no. 2, pp. 498-504 . https://doi.org/10.1111/all.13314
Publication Year :: 2017
Abstract: Background: Studies have suggested that Bacillus Calmette-Guérin (BCG) vaccination may reduce the risk of allergic diseases, including atopic dermatitis. Methods: The Danish Calmette Study was conducted 2012-2015. Within 7 days of birth new-borns were randomised 1:1 to BCG or no BCG. Exclusion criteria were gestational age

Tools